Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Spectranetics bags Covidien's drug-coated balloon

This article was originally published in Clinica

Executive Summary

As its takeover by Medtronic draws closer, Covidien has agreed to sell its Stellarex drug-coated balloon platform to Spectranetics for the seemingly bargain price of $30m. The move is thought to be an attempt to placate antitrust regulators and is subject to the closure of the $43bn mega-deal, which is expected in early 2015.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT102067

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel